Fairfax Financial Holdings, the Toronto-based property and casualty insurer and reinsurer, has agreed to commit up to US$2.3 billion to acquire a 50% stake in Boots. It is partnering with Wittington Investments, the private holding company of Canada's Weston family, in a total transaction valued at approximately US$8.9 billion, including assumed debt.
The deal covers Boots' retail operations in the UK and Ireland, Boots Opticians, the No7 Beauty Company, and Boots' Thailand and franchised businesses. Wittington will hold operational control, with Galen Weston serving as chair of Boots following completion. The transaction is expected to close in Q1 2027, subject to regulatory approvals. Farmacias Benavides and Alliance Healthcare Deutschland remain with The Boots Group's current owner and are excluded from the deal.
Boots operates 1,824 stores across the UK as of August 2025 and reported pharmacy revenue of £2.27 billion in its 2024-25 financial year, according to its own published accounts. Post-tax profit rose 23.7% to £261 million in the same period, though pharmacy revenue dipped 0.4%, partly attributed to declines in state-funded income. The business is profitable but navigating structural pressure in community pharmacy that has contributed to a gradual reduction in its store estate in recent years.
Boots is currently owned by Sycamore Partners, the US private equity firm that acquired it through its US$23.7 billion takeover of Walgreens Boots Alliance in August 2025. The sale to Fairfax and Wittington represents a rapid exit, coming approximately 13 months after Sycamore completed that acquisition.
Fairfax, whose underwriting subsidiaries include Brit and Ki at Lloyd's, Allied World, and Odyssey Re, has a long-established pattern of deploying capital into non-insurance businesses alongside its core operations. Its existing portfolio includes Recipe Unlimited, Sleep Country Canada, Sporting Life Group, and Andrew Peller.
The Boots investment follows that pattern. A US$2.3 billion outlay into a retail asset is a material deployment of capital for a group whose primary business is writing insurance and reinsurance premiums and investing the resulting float. The specific funding source for the equity commitment has not been disclosed, though Fairfax raised US$750 million in senior notes in June 2026 and an additional CA$300 million in a separate notes offering the same month, both for general corporate purposes.
Capital allocation at this scale feeds directly into the financial strength ratings and balance sheet assessments that underwriters and cedants run on any reinsurance or insurance counterparty. Fairfax's Q2 2026 results showed a combined ratio of 93.1% and underwriting profit of US$459 million going into the deal.
Prem Watsa, chairman and chief executive officer of Fairfax, said the Westons had "grown and developed some of the most successful retail brands in Canada, including in pharmacy and beauty." Weston said the family saw "a meaningful opportunity to make a great business even better, through stable, long-term ownership."
Wittington controls Loblaw Companies, Canada's largest grocery retailer with more than 2,800 locations, and through it Shoppers Drug Mart, the country's largest pharmacy, health and beauty chain. It also controls Choice Properties, Canada's largest real estate investment trust. The acquisition brings two of Canada's most prominent institutions together in a cross-border bet on one of Britain's most recognisable retail brands, with Fairfax providing the financial firepower and Wittington the operational experience in pharmacy and consumer retail.
